Nabriva Therapeutics PLC (NASDAQ:NBRV)

1.41
Delayed Data
As of 2:04pm ET
 -0.075 / -5.07%
Today’s Change
1.16
Today|||52-Week Range
3.27
+6.44%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.006.5M5.3M9.7M
 
 
 
 
Depreciation And Amortization153.0K233.0K432.0K510.0K
 
 
 
 
 
 
Operating ExpensesGross Income-153.0K------
 
 
General Expenses30.8M61.3M78.0M91.5M
 
 
 
 
 
Other Operating Expenses0.000.00700.0K0.00
 
 
Research And Development23.0M47.9M49.6M50.2M
 
 
 
 
 
Total Operating Expenses31.0M61.5M79.1M92.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-31.0M-55.0M-73.8M-82.3M
 
 
 
 
 
Extraordinary Credit6.8M0.000.000.00
 
 
Extraordinary Charge-9.4M0.000.00-32.0M
 
 
 
Interest Expense On Debt4.6M0.0043.0K133.0K
 
 
 
 
Other Expenses2.2M-858.0K492.0K-272.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-35.9M-55.6M-73.0M-114.7M
 
 
 
 
 
Income Taxes-4.0M-672.0K-1.4M-49.0K
 
 
 
 
 
Net Income-31.8M-54.9M-74.4M-114.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.1M2.1M29.8M50.8M
 
 
 
 
 
Shares To Calculate EPS Diluted1.1M2.1M29.8M50.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$30.07-$25.56-$2.49-$2.26
 
 
 
 
 
EPS Diluted-$30.07-$25.56-$2.49-$2.26